Cargando…

Network pharmacology analysis to explore mechanism of Three Flower Tea against nonalcoholic fatty liver disease with experimental support using high-fat diet-induced rats

OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) has become a common chronic liver disease that is harmful to human health. Moreover, there is currently no FDA-approved first-line drug for the treatment of nonalcoholic steatohepatitis (NASH) or NAFLD. Traditional Chinese medicine (TCM) is widely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Peixuan, Liang, Shufei, He, Yanping, Lv, Rui, Yang, Bendong, Wang, Meng, Wang, Chao, Li, Yong, Song, Xinhua, Sun, Wenlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476824/ https://www.ncbi.nlm.nih.gov/pubmed/36117665 http://dx.doi.org/10.1016/j.chmed.2022.03.002

Ejemplares similares

Prediction of Srebp-1 as a Key Target of Qing Gan San Against MAFLD in Rats via RNA-Sequencing Profile Analysis
por: Yang, Bendong, et al.
Publicado: (2021)

Deepure Tea Improves High Fat Diet-Induced Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Deng, Jing-Na, et al.
Publicado: (2015)

Effects of several tea extracts on nonalcoholic fatty liver disease in mice fed with a high‐fat diet
por: Mao, Qian‐Qian, et al.
Publicado: (2021)

Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2019)

Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
por: Zhang, Xiaobing, et al.
Publicado: (2018)

Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation
por: Xue, Hongkun, et al.
Publicado: (2022)

Pu-erh Tea Regulates Fatty Acid Metabolism in Mice Under High-Fat Diet
por: Huang, Fengjie, et al.
Publicado: (2019)

Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology
por: Yu, Chenyang, et al.
Publicado: (2023)

Promising effect of Rosa damascena extract on high-fat diet-induced nonalcoholic fatty liver
por: Davoodi, Ida, et al.
Publicado: (2017)

Explore the Mechanism of Astragalus mongholicus Bunge against Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Verification
por: Fu, Lili, et al.
Publicado: (2022)

Exercise in mice ameliorates high-fat diet-induced nonalcoholic fatty liver disease by lowering HMGCS2
por: Qian, Xiaoli, et al.
Publicado: (2021)

Metabolomics Profiling to Investigate the Pharmacologic Mechanisms of Berberine for the Treatment of High-Fat Diet-Induced Nonalcoholic Steatohepatitis
por: Li, Jian, et al.
Publicado: (2015)

Periodontitis salivary microbiota exacerbates nonalcoholic fatty liver disease in high-fat diet-induced obese mice
por: Wang, Min, et al.
Publicado: (2023)

Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease
por: Jeznach-Steinhagen, Anna, et al.
Publicado: (2019)

Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease
por: Ristic-Medic, Danijela, et al.
Publicado: (2020)

Low-Carbohydrate Diets, but Not Low-Fat Diets, Increase Nonalcoholic Fatty Liver Disease Risk in the Framingham Heart Study
por: Yiannakou, Ioanna, et al.
Publicado: (2022)

New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds
por: Yang, Bendong, et al.
Publicado: (2022)

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

Ameliorative Potential of Tamarindus indica on High Fat Diet Induced Nonalcoholic Fatty Liver Disease in Rats
por: Sasidharan, Suja Rani, et al.
Publicado: (2014)

Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl/6 Models
por: Recena Aydos, Leonardo, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Hepatocyte-Derived lncRNA MALAT1 Aggravates Pancreatic Cell Inflammation via the Inhibition of Autophagy by Upregulating YAP
por: Liu, Di, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
por: Chiu, Chien-Chao, et al.
Publicado: (2017)

Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet
por: Zhang, Ningjing, et al.
Publicado: (2020)

Dexmedetomidine ameliorates high‐fat diet‐induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice
por: Tao, Linfen, et al.
Publicado: (2020)

The Efficacy of Pharmacological Treatment in Pediatric Nonalcoholic Fatty Liver Disease
por: Cho, Taeshik, et al.
Publicado: (2012)

Ramulus Mori (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
por: Chen, Yan-Min, et al.
Publicado: (2022)

Vegetarian diet, food substitution, and nonalcoholic fatty liver
por: Chiu, Tina H., et al.
Publicado: (2018)

Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease
por: Zhou, Xiu, et al.
Publicado: (2020)

Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
por: Zhou, Tingting, et al.
Publicado: (2023)

Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease
por: Lv, Shujing, et al.
Publicado: (2018)

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)
por: Wang, Ziwen, et al.
Publicado: (2020)

Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification
por: Jiang, Guoyan, et al.
Publicado: (2022)

Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease
por: Catanzaro, Roberto, et al.
Publicado: (2016)

Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology
por: Huang, Yuanshe, et al.
Publicado: (2022)

Managing the Combination of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome with Chinese Herbal Extracts in High-Fat-Diet Fed Rats
por: Tan, Yi, et al.
Publicado: (2013)

The association of pericardial fat and peri-aortic fat with severity of nonalcoholic fatty liver disease
por: Lee, Chun-Wei, et al.
Publicado: (2022)

Exploring Anti-Nonalcoholic Fatty Liver Disease Mechanism of Gardeniae Fructus by Network Pharmacology, Molecular Docking, and Experiment Validation
por: Tang, Zhongyan, et al.
Publicado: (2022)

A Lard and Soybean Oil Mixture Alleviates Low-Fat–High-Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease in Mice
por: Yan, Sisi, et al.
Publicado: (2022)

The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease
por: Pezeshki, Ali, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f90ncvk9a1v17vpbjagpm0l5gt